Русский
Atopic dermatitis: modern ideas about etiology, pathogenesis and promising directions of pharmacotherapy (review)
DOI: https://dx.doi.org/10.18565/pharmateca.2024.5.16-21
Dzhavakhyan M.A., Bobyleva V.S., Gribkova E.I., Zvereva V.I., Dul V.N., Dhavakhyan D.R., Markaryan A.A.
1) Scientific and Educational Institute of Pharmacy n.a. K.M. Lakin, Russian University of Medicine, Moscow, Russia; 2) Experimental and Technological Department, Russian Research Institute of Medicinal and Aromatic Plants, Moscow, Russia; 3) Department of Pharmaceutical Chemistry, Pharmacognosy and Organization of Pharmaceutical Business, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia
The review presents the latest data on the prevalence of atopic dermatitis (AD); the etiology of AD, pathogenetic mechanisms of disease development and therapy are characterized in accordance with Russian clinical guidelines. The article discusses two classifications of topical glucocorticoids (tGCs) using the example of the Russian pharmaceutical market. Modern medications used for the prevention and treatment of AD in Russia and abroad are characterized.
Keywords: topical glucocorticoids (tGCs), atopic dermatitis (AD), calcineurin inhibitors, clinical guidelines
About the Autors
Corresponding author: Vitalia S. Bobyleva, Junior Researcher, Department of Chemistry of Natural Compounds, Russian Research Institute of Medicinal and Aromatic Plants, Moscow, Russia; vitaliya.bobyleva@yandex.ru
Similar Articles
